Drugs / TETRActHib
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00289185 Background | Sep 2006 → Feb 2008 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00197028 Background | Aug 2005 → Dec 2007 | Plasmodium falciparum malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TETRActHib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00289185 ↗ |
| Modality | Vaccine | “a licensed diphtheria-tetanus-pertussis Haemophilus influenzae vaccine” NCT00197028 ↗ |
| Route | Intramuscular | “by intramuscular injection a 3-dose vaccination course of RTS,S/AS02D at days 14, 44 and 74 and a 3-dose vaccination course of TETRActHib™ vaccine” NCT00197028 ↗ |